Long‐lasting inhibition of the intestinal absorption of fexofenadine by cyclosporin a in rats
Identifieur interne : 000372 ( Istex/Checkpoint ); précédent : 000371; suivant : 000373Long‐lasting inhibition of the intestinal absorption of fexofenadine by cyclosporin a in rats
Auteurs : Kei Suzuki [Japon] ; Yoshihisa Shitara [Japon] ; Kousuke Fukuda [Japon] ; Toshiharu Horie [Japon]Source :
- Journal of Pharmaceutical Sciences [ 0022-3549 ] ; 2012-07.
English descriptors
- Teeft :
- Anion, Aucp, Bioavailability, Blood concentration, Blood samples, Chiba university, Clin, Clin pharmacol, Concomitant intake, Control value, Control values, Cyclosporin, Dispos, Drug metab dispos, Fexofenadine, Fruit juices, Grapefruit juice, Hepatic, Hepatic oatps, Hepatic uptake, Inhibition, Inhibitor, Inhibitory effect, Inhibitory effects, Intestinal, Intestinal absorption, Intestinal oatps, Intestinal uptake, Intestine, Intravenous, Intravenous administration, July, Metab, Mrna, Mrna expression levels, Oatp, Oatps, Oral administration, Orange juice, Organic anion, Pharm, Pharmaceutical, Pharmaceutical sciences, Pharmacokinetics, Pharmacol, Plasma concentration, Plasma concentrations, Polypeptide, Present study, Probe drug, Rat, Residence time, Shitara, Sugiyama, Transporter, Uptake, Uptake transporters.
Abstract
The purpose of the present study is to examine the long‐lasting inhibition of intestinal organic anion transporting polypeptides (Oatps) by cyclosporin A (CsA) in rats using fexofenadine (FEX) as a probe drug. We examined the pharmacokinetics of FEX after its intravenous or oral administration to rats at 3 or 24 h after the oral administration of CsA. When FEX was administered at 3 h after the administration of CsA, its plasma concentration increased regardless of whether it was administered intravenously or orally. When FEX was intravenously administered at 24 h after the oral administration of CsA, its plasma concentration was increased; however, that observed after its oral administration was not significantly different from the vehicle‐treated control. When FEX was administered at 3 h after the administration of CsA, the hepatic availability (Fh) and the fraction absorbed in the intestine as an unchanged form (Fa·Fg) of FEX were increased, resulting in increased bioavailability (=Fa·Fg·Fh). At 24 h after the administration of CsA, the Fh of FEX was increased, whereas its bioavailability was decreased, suggesting that its Fa·Fg was decreased because of the long‐lasting inhibition. In conclusion, CsA has long‐lasting inhibitory effects on Oatps in the rat intestine as well as in the liver. © 2012 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101:2606–2615, 2012
Url:
DOI: 10.1002/jps.23174
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:2968C4F975A99209F7751FAF43FA92A66A66A4ADLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long‐lasting inhibition of the intestinal absorption of fexofenadine by cyclosporin a in rats</title>
<author><name sortKey="Suzuki, Kei" sort="Suzuki, Kei" uniqKey="Suzuki K" first="Kei" last="Suzuki">Kei Suzuki</name>
</author>
<author><name sortKey="Shitara, Yoshihisa" sort="Shitara, Yoshihisa" uniqKey="Shitara Y" first="Yoshihisa" last="Shitara">Yoshihisa Shitara</name>
</author>
<author><name sortKey="Fukuda, Kousuke" sort="Fukuda, Kousuke" uniqKey="Fukuda K" first="Kousuke" last="Fukuda">Kousuke Fukuda</name>
</author>
<author><name sortKey="Horie, Toshiharu" sort="Horie, Toshiharu" uniqKey="Horie T" first="Toshiharu" last="Horie">Toshiharu Horie</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2968C4F975A99209F7751FAF43FA92A66A66A4AD</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1002/jps.23174</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-DRJ5BN1G-9/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C62</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C62</idno>
<idno type="wicri:Area/Istex/Curation">001C62</idno>
<idno type="wicri:Area/Istex/Checkpoint">000372</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000372</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Long‐lasting inhibition of the intestinal absorption of fexofenadine by cyclosporin a in rats</title>
<author><name sortKey="Suzuki, Kei" sort="Suzuki, Kei" uniqKey="Suzuki K" first="Kei" last="Suzuki">Kei Suzuki</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Graduate School of Pharmaceutical Sciences, Chiba University, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shitara, Yoshihisa" sort="Shitara, Yoshihisa" uniqKey="Shitara Y" first="Yoshihisa" last="Shitara">Yoshihisa Shitara</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Graduate School of Pharmaceutical Sciences, Chiba University, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fukuda, Kousuke" sort="Fukuda, Kousuke" uniqKey="Fukuda K" first="Kousuke" last="Fukuda">Kousuke Fukuda</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Graduate School of Pharmaceutical Sciences, Chiba University, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Horie, Toshiharu" sort="Horie, Toshiharu" uniqKey="Horie T" first="Toshiharu" last="Horie">Toshiharu Horie</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Graduate School of Pharmaceutical Sciences, Chiba University, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Japon</country>
</affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Pharmaceutical Sciences</title>
<title level="j" type="alt">JOURNAL OF PHARMACEUTICAL SCIENCES</title>
<idno type="ISSN">0022-3549</idno>
<idno type="eISSN">1520-6017</idno>
<imprint><biblScope unit="vol">101</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="2606">2606</biblScope>
<biblScope unit="page" to="2615">2615</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2012-07">2012-07</date>
</imprint>
<idno type="ISSN">0022-3549</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-3549</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Anion</term>
<term>Aucp</term>
<term>Bioavailability</term>
<term>Blood concentration</term>
<term>Blood samples</term>
<term>Chiba university</term>
<term>Clin</term>
<term>Clin pharmacol</term>
<term>Concomitant intake</term>
<term>Control value</term>
<term>Control values</term>
<term>Cyclosporin</term>
<term>Dispos</term>
<term>Drug metab dispos</term>
<term>Fexofenadine</term>
<term>Fruit juices</term>
<term>Grapefruit juice</term>
<term>Hepatic</term>
<term>Hepatic oatps</term>
<term>Hepatic uptake</term>
<term>Inhibition</term>
<term>Inhibitor</term>
<term>Inhibitory effect</term>
<term>Inhibitory effects</term>
<term>Intestinal</term>
<term>Intestinal absorption</term>
<term>Intestinal oatps</term>
<term>Intestinal uptake</term>
<term>Intestine</term>
<term>Intravenous</term>
<term>Intravenous administration</term>
<term>July</term>
<term>Metab</term>
<term>Mrna</term>
<term>Mrna expression levels</term>
<term>Oatp</term>
<term>Oatps</term>
<term>Oral administration</term>
<term>Orange juice</term>
<term>Organic anion</term>
<term>Pharm</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical sciences</term>
<term>Pharmacokinetics</term>
<term>Pharmacol</term>
<term>Plasma concentration</term>
<term>Plasma concentrations</term>
<term>Polypeptide</term>
<term>Present study</term>
<term>Probe drug</term>
<term>Rat</term>
<term>Residence time</term>
<term>Shitara</term>
<term>Sugiyama</term>
<term>Transporter</term>
<term>Uptake</term>
<term>Uptake transporters</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The purpose of the present study is to examine the long‐lasting inhibition of intestinal organic anion transporting polypeptides (Oatps) by cyclosporin A (CsA) in rats using fexofenadine (FEX) as a probe drug. We examined the pharmacokinetics of FEX after its intravenous or oral administration to rats at 3 or 24 h after the oral administration of CsA. When FEX was administered at 3 h after the administration of CsA, its plasma concentration increased regardless of whether it was administered intravenously or orally. When FEX was intravenously administered at 24 h after the oral administration of CsA, its plasma concentration was increased; however, that observed after its oral administration was not significantly different from the vehicle‐treated control. When FEX was administered at 3 h after the administration of CsA, the hepatic availability (Fh) and the fraction absorbed in the intestine as an unchanged form (Fa·Fg) of FEX were increased, resulting in increased bioavailability (=Fa·Fg·Fh). At 24 h after the administration of CsA, the Fh of FEX was increased, whereas its bioavailability was decreased, suggesting that its Fa·Fg was decreased because of the long‐lasting inhibition. In conclusion, CsA has long‐lasting inhibitory effects on Oatps in the rat intestine as well as in the liver. © 2012 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101:2606–2615, 2012</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Suzuki, Kei" sort="Suzuki, Kei" uniqKey="Suzuki K" first="Kei" last="Suzuki">Kei Suzuki</name>
</noRegion>
<name sortKey="Fukuda, Kousuke" sort="Fukuda, Kousuke" uniqKey="Fukuda K" first="Kousuke" last="Fukuda">Kousuke Fukuda</name>
<name sortKey="Horie, Toshiharu" sort="Horie, Toshiharu" uniqKey="Horie T" first="Toshiharu" last="Horie">Toshiharu Horie</name>
<name sortKey="Horie, Toshiharu" sort="Horie, Toshiharu" uniqKey="Horie T" first="Toshiharu" last="Horie">Toshiharu Horie</name>
<name sortKey="Shitara, Yoshihisa" sort="Shitara, Yoshihisa" uniqKey="Shitara Y" first="Yoshihisa" last="Shitara">Yoshihisa Shitara</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000372 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000372 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:2968C4F975A99209F7751FAF43FA92A66A66A4AD |texte= Long‐lasting inhibition of the intestinal absorption of fexofenadine by cyclosporin a in rats }}
This area was generated with Dilib version V0.6.33. |